Martin Maguire resumes & CV records
Resumes
Martin Maguire
Martin C Maguire, 38Worcester, MA
Martin Maguire Phones & Addresses
Worcester, MA
5 Foxhill Rd, Shrewsbury, MA 01545 508-8420044
Bristol, RI
Mentions for Martin C Maguire
Publications & IP owners
Us Patents
Antagonists Of Melanin Concentrating Hormone Receptor
US Patent:
6921821, Jul 26, 2005
Filed:
Jun 11, 2003
Appl. No.:
10/459682
Inventors:
Christopher Blackburn - Natick MA, US
Su-Jen Lai - Somerville MA, US
Jennifer L. Che - Cambridge MA, US
Martin P. Maguire - Woburn MA, US
Michael A. Patane - Andover MA, US
Matthew J. LaMarche - Reading MA, US
Courtney A. Cullis - Belmont MA, US
James Brown - Framingham MA, US
Anil Vasudevan - Gurnee IL, US
Jennifer C. Freeman - Grayslake IL, US
Mathew M. Mulhern - Hainesville IL, US
John K. Lynch - Kenosha WI, US
Ju Gao - Gurnee IL, US
Dariusz Wodka - Waukegan IL, US
Andrew J. Souers - Evanston IL, US
Rajesh Iyengar - Lindenhurst IL, US
Mary Katherin Verzal - Burlington WI, US
Philip R. Kym - Grayslake IL, US
Su-Jen Lai - Somerville MA, US
Jennifer L. Che - Cambridge MA, US
Martin P. Maguire - Woburn MA, US
Michael A. Patane - Andover MA, US
Matthew J. LaMarche - Reading MA, US
Courtney A. Cullis - Belmont MA, US
James Brown - Framingham MA, US
Anil Vasudevan - Gurnee IL, US
Jennifer C. Freeman - Grayslake IL, US
Mathew M. Mulhern - Hainesville IL, US
John K. Lynch - Kenosha WI, US
Ju Gao - Gurnee IL, US
Dariusz Wodka - Waukegan IL, US
Andrew J. Souers - Evanston IL, US
Rajesh Iyengar - Lindenhurst IL, US
Mary Katherin Verzal - Burlington WI, US
Philip R. Kym - Grayslake IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D205/08
C07D401/00
C07D239/02
C07D401/00
C07D239/02
US Classification:
540364, 540601, 544284, 544324, 546157, 514312
Abstract:
This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1). The compounds are represented by formula I: where m is zero or one, n is zero to two, Y is oxygen or —N(R)—, R, R, R, R, R, Rand Ring A are defined in the specification. Coumarin and quinolone compounds where Rand Rtogether form a fused benzo ring are preferred. The invention also provides compounds of formula VI where the coumarin moiety is replaced by a quinazolinone ring. The compounds are useful for treating MCH-R1-related disorders, particularly overweight conditions including obesity.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.